1.2.40.0.34.10.73

1 Value Set ELGA_whoATC

ELGA Valueset für ATC

1.1 Aktuelle Version

Diese Terminologie ist eine Momentaufnahme vom . Terminologien können sich im Laufe der Zeit weiterentwickeln. Wenn eine neuere (dynamische) Versionen dieser Terminologie benötigt wird, bitte von der Quelle abrufen.
Id	1.2.40.0.34.10.73	Gültigkeit	2013‑01‑10
Status	Definitiv	Versions-Label
Name	ELGA_whoATC	Bezeichnung	ELGA_whoATC
Beschreibung	ELGA Valueset für ATC
Quell-Codesystem	2.16.840.1.113883.6.73 - WHO Anatomical Therapeutic Chemical classification - FHIR: http://www.whocc.no/atc - HL7 V2: WC
Level/ Typ Code Bezeichnung Codesystem 0‑L A Alimentäres System und Stoffwechsel WHO Anatomical Therapeutic Chemical classification 0‑L A01 Stomatologika WHO Anatomical Therapeutic Chemical classification 0‑L A01a Stomatologika WHO Anatomical Therapeutic Chemical classification 0‑L A01AA Mittel zur Kariesprophylaxe WHO Anatomical Therapeutic Chemical classification 0‑L A01AA01 Natriumfluorid WHO Anatomical Therapeutic Chemical classification 0‑L A01AA02 Natriummonofluorphosphat WHO Anatomical Therapeutic Chemical classification 0‑L A01AA03 Olaflur WHO Anatomical Therapeutic Chemical classification 0‑L A01AA04 Zinn(II)-fluorid WHO Anatomical Therapeutic Chemical classification 0‑L A01AA30 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A01AA51 Natriumfluorid, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A01AB Antiinfektiva und Antiseptika zur oralen Lokalbehandlung WHO Anatomical Therapeutic Chemical classification 0‑L A01AB02 Wasserstoffperoxid WHO Anatomical Therapeutic Chemical classification 0‑L A01AB03 Chlorhexidin WHO Anatomical Therapeutic Chemical classification 0‑L A01AB04 Amphotericin B WHO Anatomical Therapeutic Chemical classification 0‑L A01AB05 Polynoxylin WHO Anatomical Therapeutic Chemical classification 0‑L A01AB06 Domiphen WHO Anatomical Therapeutic Chemical classification 0‑L A01AB07 Oxychinolin WHO Anatomical Therapeutic Chemical classification 0‑L A01AB08 Neomycin WHO Anatomical Therapeutic Chemical classification 0‑L A01AB09 Miconazol WHO Anatomical Therapeutic Chemical classification 0‑L A01AB10 Natamycin WHO Anatomical Therapeutic Chemical classification 0‑L A01AB11 Verschiedene WHO Anatomical Therapeutic Chemical classification 0‑L A01AB12 Hexetidin WHO Anatomical Therapeutic Chemical classification 0‑L A01AB13 Tetracyclin WHO Anatomical Therapeutic Chemical classification 0‑L A01AB14 Benzoxoniumchlorid WHO Anatomical Therapeutic Chemical classification 0‑L A01AB15 Tibezoniumiodid WHO Anatomical Therapeutic Chemical classification 0‑L A01AB16 Mepartricin WHO Anatomical Therapeutic Chemical classification 0‑L A01AB17 Metronidazol WHO Anatomical Therapeutic Chemical classification 0‑L A01AB18 Clotrimazol WHO Anatomical Therapeutic Chemical classification 0‑L A01AB19 Natriumperborat WHO Anatomical Therapeutic Chemical classification 0‑L A01AB21 Chlortetracyclin WHO Anatomical Therapeutic Chemical classification 0‑L A01AB22 Doxycyclin WHO Anatomical Therapeutic Chemical classification 0‑L A01AB23 Minocyclin WHO Anatomical Therapeutic Chemical classification 0‑L A01AC Corticosteroide zur oralen Lokalbehandlung WHO Anatomical Therapeutic Chemical classification 0‑L A01AC01 Triamcinolon WHO Anatomical Therapeutic Chemical classification 0‑L A01AC02 Dexamethason WHO Anatomical Therapeutic Chemical classification 0‑L A01AC03 Hydrocortison WHO Anatomical Therapeutic Chemical classification 0‑L A01AC54 Prednisolon, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A01AD Andere Mittel zur oralen Lokalbehandlung WHO Anatomical Therapeutic Chemical classification 0‑L A01AD01 Epinephrin WHO Anatomical Therapeutic Chemical classification 0‑L A01AD02 Benzydamin WHO Anatomical Therapeutic Chemical classification 0‑L A01AD05 Acetylsalicylsäure WHO Anatomical Therapeutic Chemical classification 0‑L A01AD06 Adrenalon WHO Anatomical Therapeutic Chemical classification 0‑L A01AD07 Amlexanox WHO Anatomical Therapeutic Chemical classification 0‑L A01AD11 Verschiedene WHO Anatomical Therapeutic Chemical classification 0‑L A02 Mittel bei säure bedingten Erkrankungen WHO Anatomical Therapeutic Chemical classification 0‑L A02A Antacida WHO Anatomical Therapeutic Chemical classification 0‑L A02AA Magnesium-haltige Verbindungen WHO Anatomical Therapeutic Chemical classification 0‑L A02AA01 Magnesiumcarbonat WHO Anatomical Therapeutic Chemical classification 0‑L A02AA02 Magnesiumoxid WHO Anatomical Therapeutic Chemical classification 0‑L A02AA03 Magnesiumperoxid WHO Anatomical Therapeutic Chemical classification 0‑L A02AA04 Magnesiumhydroxid WHO Anatomical Therapeutic Chemical classification 0‑L A02AA05 Magnesiumsilikat WHO Anatomical Therapeutic Chemical classification 0‑L A02AA10 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A02AB Aluminium-haltige Verbindungen WHO Anatomical Therapeutic Chemical classification 0‑L A02AB01 Aluminiumhydroxid WHO Anatomical Therapeutic Chemical classification 0‑L A02AB02 Algeldrat WHO Anatomical Therapeutic Chemical classification 0‑L A02AB03 Aluminiumphosphat WHO Anatomical Therapeutic Chemical classification 0‑L A02AB04 Dihydroxyalumiumnatriumcarbonat WHO Anatomical Therapeutic Chemical classification 0‑L A02AB05 Aluminiumacetoacetat WHO Anatomical Therapeutic Chemical classification 0‑L A02AB06 Aloglutamol WHO Anatomical Therapeutic Chemical classification 0‑L A02AB07 Aluminiumglycinat WHO Anatomical Therapeutic Chemical classification 0‑L A02AB10 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A02AC Calcium-haltige Verbindungen WHO Anatomical Therapeutic Chemical classification 0‑L A02AC01 Calciumcarbonat WHO Anatomical Therapeutic Chemical classification 0‑L A02AC02 Calciumsilikat WHO Anatomical Therapeutic Chemical classification 0‑L A02AC10 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A02AD Kombinationen und Komplexe von Aluminium-, Calcium- und Magnesium-haltigen Verbindungen WHO Anatomical Therapeutic Chemical classification 0‑L A02AD01 Einfache Salzkombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A02AD02 Magaldrat WHO Anatomical Therapeutic Chemical classification 0‑L A02AD03 Almagat WHO Anatomical Therapeutic Chemical classification 0‑L A02AD04 Hydrotalcit WHO Anatomical Therapeutic Chemical classification 0‑L A02AD05 Almasilat WHO Anatomical Therapeutic Chemical classification 0‑L A02AF Antacida mit Karminativa WHO Anatomical Therapeutic Chemical classification 0‑L A02AF01 Magaldrat und Karminativa WHO Anatomical Therapeutic Chemical classification 0‑L A02AF02 Einfache Salzkombinationen und Karminativa WHO Anatomical Therapeutic Chemical classification 0‑L A02AG Antacida mit Spasmolytika WHO Anatomical Therapeutic Chemical classification 0‑L A02AH Antacida mit Natriumbicarbonat WHO Anatomical Therapeutic Chemical classification 0‑L A02AX Antacida, andere Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A02B Mittel bei peptischem Ulkus und gastroesophagealer Refluxkrankheit WHO Anatomical Therapeutic Chemical classification 0‑L A02BA Histamin-H2-Rezeptorantagonisten WHO Anatomical Therapeutic Chemical classification 0‑L A02BA01 Cimetidin WHO Anatomical Therapeutic Chemical classification 0‑L A02BA02 Ranitidin WHO Anatomical Therapeutic Chemical classification 0‑L A02BA03 Famotidin WHO Anatomical Therapeutic Chemical classification 0‑L A02BA04 Nizatidin WHO Anatomical Therapeutic Chemical classification 0‑L A02BA05 Niperotidin WHO Anatomical Therapeutic Chemical classification 0‑L A02BA06 Roxatidin WHO Anatomical Therapeutic Chemical classification 0‑L A02BA07 Ranitidinbismutcitrat WHO Anatomical Therapeutic Chemical classification 0‑L A02BA08 Lafutidin WHO Anatomical Therapeutic Chemical classification 0‑L A02BA51 Cimetidin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A02BA53 Famotidin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A02BB Prostaglandine WHO Anatomical Therapeutic Chemical classification 0‑L A02BB01 Misoprostol WHO Anatomical Therapeutic Chemical classification 0‑L A02BB02 Enprostil WHO Anatomical Therapeutic Chemical classification 0‑L A02BC Protonenpumpenhemmer WHO Anatomical Therapeutic Chemical classification 0‑L A02BC01 Omeprazol WHO Anatomical Therapeutic Chemical classification 0‑L A02BC02 Pantoprazol WHO Anatomical Therapeutic Chemical classification 0‑L A02BC03 Lansoprazol WHO Anatomical Therapeutic Chemical classification 0‑L A02BC04 Rabeprazol WHO Anatomical Therapeutic Chemical classification 0‑L A02BC05 Esomeprazol WHO Anatomical Therapeutic Chemical classification 0‑L A02BC06 Dexlansoprazol WHO Anatomical Therapeutic Chemical classification 0‑L A02BD Kombinationen zur Eradikation von Helicobacter pylori WHO Anatomical Therapeutic Chemical classification 0‑L A02BD01 Omeprazol, Amoxicillin und Metronidazol WHO Anatomical Therapeutic Chemical classification 0‑L A02BD02 Lansoprazol, Tetracyclin und Metronidazol WHO Anatomical Therapeutic Chemical classification 0‑L A02BD03 Lansoprazol, Amoxicillin und Metronidazol WHO Anatomical Therapeutic Chemical classification 0‑L A02BD04 Pantoprazol, Amoxicillin und Clarithromycin WHO Anatomical Therapeutic Chemical classification 0‑L A02BD05 Omeprazol, Amoxicillin und Clarithromycin WHO Anatomical Therapeutic Chemical classification 0‑L A02BD06 Esomeprazol, Amoxicillin und Clarithromycin WHO Anatomical Therapeutic Chemical classification 0‑L A02BD08 Bismutsubcitrat, Tetracyclin und Metronidazol WHO Anatomical Therapeutic Chemical classification 0‑L A02BX Andere Mittel bei peptischem Ulkus und gastroesophagealer Refluxkrankheit WHO Anatomical Therapeutic Chemical classification 0‑L A02BX01 Carbenoxolon WHO Anatomical Therapeutic Chemical classification 0‑L A02BX02 Sucralfat WHO Anatomical Therapeutic Chemical classification 0‑L A02BX03 Pirenzepin WHO Anatomical Therapeutic Chemical classification 0‑L A02BX04 Methiosulfoniumchlorid WHO Anatomical Therapeutic Chemical classification 0‑L A02BX05 Bismutsubcitrat WHO Anatomical Therapeutic Chemical classification 0‑L A02BX06 Proglumid WHO Anatomical Therapeutic Chemical classification 0‑L A02BX07 Gefarnat WHO Anatomical Therapeutic Chemical classification 0‑L A02BX08 Sulglicotid WHO Anatomical Therapeutic Chemical classification 0‑L A02BX09 Acetoxolon WHO Anatomical Therapeutic Chemical classification 0‑L A02BX10 Zolimidin WHO Anatomical Therapeutic Chemical classification 0‑L A02BX11 Troxipid WHO Anatomical Therapeutic Chemical classification 0‑L A02BX12 Bismutsubnitrat WHO Anatomical Therapeutic Chemical classification 0‑L A02BX13 Alginsäure WHO Anatomical Therapeutic Chemical classification 0‑L A02BX51 Carbenoxolon, Kombinationen exkl. Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L A02BX71 Carbenoxolon, Kombinationen mit Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L A02BX77 Gefarnat, Kombinationen mit Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L A02X Andere Mittel bei säure bedingten Erkrankungen WHO Anatomical Therapeutic Chemical classification 0‑L A03 Mittel bei funktionellen gastrointestinalen Störungen WHO Anatomical Therapeutic Chemical classification 0‑L A03A Mittel bei funktionellen Störungen des Darms WHO Anatomical Therapeutic Chemical classification 0‑L A03AA Synthetische Anticholinergika, Ester mit tertiären Aminogruppen WHO Anatomical Therapeutic Chemical classification 0‑L A03AA01 Oxyphencyclimin WHO Anatomical Therapeutic Chemical classification 0‑L A03AA03 Camylofin WHO Anatomical Therapeutic Chemical classification 0‑L A03AA04 Mebeverin WHO Anatomical Therapeutic Chemical classification 0‑L A03AA05 Trimebutin WHO Anatomical Therapeutic Chemical classification 0‑L A03AA06 Rociverin WHO Anatomical Therapeutic Chemical classification 0‑L A03AA07 Dicycloverin WHO Anatomical Therapeutic Chemical classification 0‑L A03AA08 Dihexyverin WHO Anatomical Therapeutic Chemical classification 0‑L A03AA09 Difemerin WHO Anatomical Therapeutic Chemical classification 0‑L A03AA30 Piperidolat WHO Anatomical Therapeutic Chemical classification 0‑L A03AB Synthetische Anticholinergika, quartäre Ammonium-Verbindungen WHO Anatomical Therapeutic Chemical classification 0‑L A03AB01 Benzilon WHO Anatomical Therapeutic Chemical classification 0‑L A03AB02 Glycopyrronium WHO Anatomical Therapeutic Chemical classification 0‑L A03AB03 Oxyphenonium WHO Anatomical Therapeutic Chemical classification 0‑L A03AB04 Penthienat WHO Anatomical Therapeutic Chemical classification 0‑L A03AB05 Propanthelin WHO Anatomical Therapeutic Chemical classification 0‑L A03AB06 Otiloniumbromid WHO Anatomical Therapeutic Chemical classification 0‑L A03AB07 Methanthelinium WHO Anatomical Therapeutic Chemical classification 0‑L A03AB08 Tridihexethyl WHO Anatomical Therapeutic Chemical classification 0‑L A03AB09 Isopropamid WHO Anatomical Therapeutic Chemical classification 0‑L A03AB10 Hexocyclium WHO Anatomical Therapeutic Chemical classification 0‑L A03AB11 Poldin WHO Anatomical Therapeutic Chemical classification 0‑L A03AB12 Mepenzolat WHO Anatomical Therapeutic Chemical classification 0‑L A03AB13 Bevonium WHO Anatomical Therapeutic Chemical classification 0‑L A03AB14 Pipenzolat WHO Anatomical Therapeutic Chemical classification 0‑L A03AB15 Diphemanil WHO Anatomical Therapeutic Chemical classification 0‑L A03AB16 (2-Benzhydryloxyethyl)diethylmethyl-ammoniumiodid WHO Anatomical Therapeutic Chemical classification 0‑L A03AB17 Tiemoniumiodid WHO Anatomical Therapeutic Chemical classification 0‑L A03AB18 Prifiniumbromid WHO Anatomical Therapeutic Chemical classification 0‑L A03AB19 Timepidiumbromid WHO Anatomical Therapeutic Chemical classification 0‑L A03AB21 Fenpiverinium WHO Anatomical Therapeutic Chemical classification 0‑L A03AB53 Oxyphenonium, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A03AC Synthetische Spasmolytika, Amide mit tertiären Aminen WHO Anatomical Therapeutic Chemical classification 0‑L A03AC02 Dimethylaminopropionylphenothiazin WHO Anatomical Therapeutic Chemical classification 0‑L A03AC04 Nicofetamid WHO Anatomical Therapeutic Chemical classification 0‑L A03AC05 Tiropramid WHO Anatomical Therapeutic Chemical classification 0‑L A03AD Papaverin und Derivate WHO Anatomical Therapeutic Chemical classification 0‑L A03AD01 Papaverin WHO Anatomical Therapeutic Chemical classification 0‑L A03AD02 Drotaverin WHO Anatomical Therapeutic Chemical classification 0‑L A03AD30 Moxaverin WHO Anatomical Therapeutic Chemical classification 0‑L A03AE Auf Serotonin-Rezeptoren wirkende Mittel WHO Anatomical Therapeutic Chemical classification 0‑L A03AE01 Alosetron WHO Anatomical Therapeutic Chemical classification 0‑L A03AE02 Tegaserod WHO Anatomical Therapeutic Chemical classification 0‑L A03AE03 Cilansetron WHO Anatomical Therapeutic Chemical classification 0‑L A03AX Andere Mittel bei funktionellen Störungen des Darms WHO Anatomical Therapeutic Chemical classification 0‑L A03AX01 Fenpipran WHO Anatomical Therapeutic Chemical classification 0‑L A03AX02 Diisopromin WHO Anatomical Therapeutic Chemical classification 0‑L A03AX03 Chlorbenzoxamin WHO Anatomical Therapeutic Chemical classification 0‑L A03AX04 Pinaverium WHO Anatomical Therapeutic Chemical classification 0‑L A03AX05 Fenoverin WHO Anatomical Therapeutic Chemical classification 0‑L A03AX06 Idanpramin WHO Anatomical Therapeutic Chemical classification 0‑L A03AX07 Proxazol WHO Anatomical Therapeutic Chemical classification 0‑L A03AX08 Alverin WHO Anatomical Therapeutic Chemical classification 0‑L A03AX09 Trepibuton WHO Anatomical Therapeutic Chemical classification 0‑L A03AX10 Isomethepten WHO Anatomical Therapeutic Chemical classification 0‑L A03AX11 Caroverin WHO Anatomical Therapeutic Chemical classification 0‑L A03AX12 Phloroglucinol WHO Anatomical Therapeutic Chemical classification 0‑L A03AX13 Silikone WHO Anatomical Therapeutic Chemical classification 0‑L A03AX30 Trimethyldiphenylpropylamin WHO Anatomical Therapeutic Chemical classification 0‑L A03AX58 Alverin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A03B BELLADONNA UND DERIVATE, REIN WHO Anatomical Therapeutic Chemical classification 0‑L A03BA Belladonna-Alkaloide, tertiäre Amine WHO Anatomical Therapeutic Chemical classification 0‑L A03BA01 Atropin WHO Anatomical Therapeutic Chemical classification 0‑L A03BA03 Hyoscyamin WHO Anatomical Therapeutic Chemical classification 0‑L A03BA04 Belladonna-Gesamtalkaloide WHO Anatomical Therapeutic Chemical classification 0‑L A03BB Belladonna-Alkaloide, halbsynthetisch, quartäre Ammonium-Verbindungen WHO Anatomical Therapeutic Chemical classification 0‑L A03BB01 Butylscopolamin WHO Anatomical Therapeutic Chemical classification 0‑L A03BB02 Methylatropin WHO Anatomical Therapeutic Chemical classification 0‑L A03BB03 Methylscopolamin WHO Anatomical Therapeutic Chemical classification 0‑L A03BB04 Fentonium WHO Anatomical Therapeutic Chemical classification 0‑L A03BB05 Cimetropiumbromid WHO Anatomical Therapeutic Chemical classification 0‑L A03C Spasmolytika in Kombination mit Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L A03CA Synthetische Anticholinergika in Kombination mit Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L A03CA01 Isopropamid und Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L A03CA02 Clidinium und Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L A03CA03 Oxyphencyclimin und Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L A03CA04 Otiloniumbromid und Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L A03CA05 Glycopyrronium und Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L A03CA06 Bevonium und Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L A03CA07 Ambutonium und Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L A03CA08 Diphemanil und Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L A03CA30 Emepronium und Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L A03CA34 Propanthelin und Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L A03CB Belladonna und Derivate in Kombination mit Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L A03CB01 Methylscopolamin und Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L A03CB02 Belladonna-Gesamtalkaloide und Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L A03CB03 Atropin und Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L A03CB04 Methylhomatropin und Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L A03CB31 Hyoscyamin und Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L A03CC Andere Spasmolytika in Kombination mit Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L A03D Spasmolytika in Kombination mit Analgetika WHO Anatomical Therapeutic Chemical classification 0‑L A03DA Synthetische Anticholinergika in Kombination mit Analgetika WHO Anatomical Therapeutic Chemical classification 0‑L A03DA01 Tropenzilon und Analgetika WHO Anatomical Therapeutic Chemical classification 0‑L A03DA02 Pitofenon und Analgetika WHO Anatomical Therapeutic Chemical classification 0‑L A03DA03 Bevonium und Analgetika WHO Anatomical Therapeutic Chemical classification 0‑L A03DA04 Ciclonium und Analgetika WHO Anatomical Therapeutic Chemical classification 0‑L A03DA05 Camylofin und Analgetika WHO Anatomical Therapeutic Chemical classification 0‑L A03DA06 Trospium und Analgetika WHO Anatomical Therapeutic Chemical classification 0‑L A03DA07 Tiemoniumiodid und Analgetika WHO Anatomical Therapeutic Chemical classification 0‑L A03DB Belladonna und Derivate in Kombination mit Analgetika WHO Anatomical Therapeutic Chemical classification 0‑L A03DB04 Butylscopolamin und Analgetika WHO Anatomical Therapeutic Chemical classification 0‑L A03DC Andere Spasmolytika in Kombination mit Analgetika WHO Anatomical Therapeutic Chemical classification 0‑L A03E Spasmolytika und Anticholinergika in Kombination mit anderen Mitteln WHO Anatomical Therapeutic Chemical classification 0‑L A03EA Spasmolytika, Psycholeptika und Analgetika in Kombination WHO Anatomical Therapeutic Chemical classification 0‑L A03ED Spasmolytika in Kombination mit anderen Mitteln WHO Anatomical Therapeutic Chemical classification 0‑L A03F Prokinetika WHO Anatomical Therapeutic Chemical classification 0‑L A03FA Prokinetika WHO Anatomical Therapeutic Chemical classification 0‑L A03FA01 Metoclopramid WHO Anatomical Therapeutic Chemical classification 0‑L A03FA02 Cisaprid WHO Anatomical Therapeutic Chemical classification 0‑L A03FA03 Domperidon WHO Anatomical Therapeutic Chemical classification 0‑L A03FA04 Bromoprid WHO Anatomical Therapeutic Chemical classification 0‑L A03FA05 Alizaprid WHO Anatomical Therapeutic Chemical classification 0‑L A03FA06 Cleboprid WHO Anatomical Therapeutic Chemical classification 0‑L A04 Antiemetika und Mittel gegen Übelkeit WHO Anatomical Therapeutic Chemical classification 0‑L A04A Antiemetika und Mittel gegen Übelkeit WHO Anatomical Therapeutic Chemical classification 0‑L A04AA Serotonin-5HT3-Antagonisten WHO Anatomical Therapeutic Chemical classification 0‑L A04AA01 Ondansetron WHO Anatomical Therapeutic Chemical classification 0‑L A04AA02 Granisetron WHO Anatomical Therapeutic Chemical classification 0‑L A04AA03 Tropisetron WHO Anatomical Therapeutic Chemical classification 0‑L A04AA04 Dolasetron WHO Anatomical Therapeutic Chemical classification 0‑L A04AA05 Palonosetron WHO Anatomical Therapeutic Chemical classification 0‑L A04AD Andere Antiemetika WHO Anatomical Therapeutic Chemical classification 0‑L A04AD01 Scopolamin WHO Anatomical Therapeutic Chemical classification 0‑L A04AD02 Ceriumoxalat WHO Anatomical Therapeutic Chemical classification 0‑L A04AD04 Chlorbutanol WHO Anatomical Therapeutic Chemical classification 0‑L A04AD05 Metopimazin WHO Anatomical Therapeutic Chemical classification 0‑L A04AD10 Dronabinol WHO Anatomical Therapeutic Chemical classification 0‑L A04AD11 Nabilon WHO Anatomical Therapeutic Chemical classification 0‑L A04AD12 Aprepitant WHO Anatomical Therapeutic Chemical classification 0‑L A04AD51 Scopolamin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A04AD54 Chlorbutanol, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A05 Gallen- und Lebertherapie WHO Anatomical Therapeutic Chemical classification 0‑L A05A Gallentherapie WHO Anatomical Therapeutic Chemical classification 0‑L A05AA Gallensäure-haltige Zubereitungen WHO Anatomical Therapeutic Chemical classification 0‑L A05AA01 Chenodeoxycholsäure WHO Anatomical Therapeutic Chemical classification 0‑L A05AA02 Ursodeoxycholsäure WHO Anatomical Therapeutic Chemical classification 0‑L A05AB Zubereitungen zur Gallentherapie WHO Anatomical Therapeutic Chemical classification 0‑L A05AB01 N-(Hydroxymethyl)nicotinamid WHO Anatomical Therapeutic Chemical classification 0‑L A05AX Andere Mittel zur Gallentherapie WHO Anatomical Therapeutic Chemical classification 0‑L A05AX01 Piprozolin WHO Anatomical Therapeutic Chemical classification 0‑L A05AX02 Hymecromon WHO Anatomical Therapeutic Chemical classification 0‑L A05AX03 Cyclobutyrol WHO Anatomical Therapeutic Chemical classification 0‑L A05B Lebertherapie, Lipotrope Substanzen WHO Anatomical Therapeutic Chemical classification 0‑L A05BA Lebertherapie WHO Anatomical Therapeutic Chemical classification 0‑L A05BA01 Argininglutamat WHO Anatomical Therapeutic Chemical classification 0‑L A05BA03 Silymarin WHO Anatomical Therapeutic Chemical classification 0‑L A05BA04 Citiolon WHO Anatomical Therapeutic Chemical classification 0‑L A05BA05 Epomediol WHO Anatomical Therapeutic Chemical classification 0‑L A05BA06 Ornithinoxoglurat WHO Anatomical Therapeutic Chemical classification 0‑L A05BA07 Tidiacicarginin WHO Anatomical Therapeutic Chemical classification 0‑L A05C Mittel zur Gallentherapie und Lipotrope Substanzen in Kombination WHO Anatomical Therapeutic Chemical classification 0‑L A06 Laxanzien WHO Anatomical Therapeutic Chemical classification 0‑L A06A Laxanzien WHO Anatomical Therapeutic Chemical classification 0‑L A06AA Gleitmittel, Emollientia WHO Anatomical Therapeutic Chemical classification 0‑L A06AA01 Dickflüssiges Paraffin WHO Anatomical Therapeutic Chemical classification 0‑L A06AA02 Docusat-Natrium WHO Anatomical Therapeutic Chemical classification 0‑L A06AA51 Dickflüssiges Paraffin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A06AB Kontaktlaxanzien WHO Anatomical Therapeutic Chemical classification 0‑L A06AB01 Oxyphenisatin WHO Anatomical Therapeutic Chemical classification 0‑L A06AB02 Bisacodyl WHO Anatomical Therapeutic Chemical classification 0‑L A06AB03 Dantron WHO Anatomical Therapeutic Chemical classification 0‑L A06AB04 Phenolphthalein WHO Anatomical Therapeutic Chemical classification 0‑L A06AB05 Rizinusöl WHO Anatomical Therapeutic Chemical classification 0‑L A06AB06 Sennoside WHO Anatomical Therapeutic Chemical classification 0‑L A06AB07 Cascara WHO Anatomical Therapeutic Chemical classification 0‑L A06AB08 Natriumpicosulfat WHO Anatomical Therapeutic Chemical classification 0‑L A06AB09 Bisoxatin WHO Anatomical Therapeutic Chemical classification 0‑L A06AB20 Kontaktlaxanzien in Kombination WHO Anatomical Therapeutic Chemical classification 0‑L A06AB30 Kontaktlaxanzien in Kombination mit Belladonna-Alkaloiden WHO Anatomical Therapeutic Chemical classification 0‑L A06AB52 Bisacodyl, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A06AB53 Dantron, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A06AB56 Sennoside, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A06AB57 Cascara, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A06AB58 Natriumpicosulfat, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A06AC Quellmittel WHO Anatomical Therapeutic Chemical classification 0‑L A06AC01 Ispaghula (Flohsamen) WHO Anatomical Therapeutic Chemical classification 0‑L A06AC02 Ethulose WHO Anatomical Therapeutic Chemical classification 0‑L A06AC03 Sterculia WHO Anatomical Therapeutic Chemical classification 0‑L A06AC05 Leinsamen WHO Anatomical Therapeutic Chemical classification 0‑L A06AC06 Methylcellulose WHO Anatomical Therapeutic Chemical classification 0‑L A06AC07 Triticum (Weizenkleie) WHO Anatomical Therapeutic Chemical classification 0‑L A06AC08 Polycarbophil-Calcium WHO Anatomical Therapeutic Chemical classification 0‑L A06AC51 Ispaghula, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A06AC53 Sterculia, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A06AC55 Leinsamen, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A06AD Osmotisch wirkende Laxanzien WHO Anatomical Therapeutic Chemical classification 0‑L A06AD01 Magnesiumcarbonat WHO Anatomical Therapeutic Chemical classification 0‑L A06AD02 Magnesiumoxid WHO Anatomical Therapeutic Chemical classification 0‑L A06AD03 Magnesiumperoxid WHO Anatomical Therapeutic Chemical classification 0‑L A06AD04 Magnesiumsulfat WHO Anatomical Therapeutic Chemical classification 0‑L A06AD10 Mineralsalze in Kombination WHO Anatomical Therapeutic Chemical classification 0‑L A06AD11 Lactulose WHO Anatomical Therapeutic Chemical classification 0‑L A06AD12 Lactitol WHO Anatomical Therapeutic Chemical classification 0‑L A06AD13 Natriumsulfat WHO Anatomical Therapeutic Chemical classification 0‑L A06AD14 Pentaerythrityl WHO Anatomical Therapeutic Chemical classification 0‑L A06AD15 Macrogol WHO Anatomical Therapeutic Chemical classification 0‑L A06AD16 Mannitol WHO Anatomical Therapeutic Chemical classification 0‑L A06AD17 Natriumphosphat WHO Anatomical Therapeutic Chemical classification 0‑L A06AD18 Sorbitol WHO Anatomical Therapeutic Chemical classification 0‑L A06AD19 Magnesiumcitrat WHO Anatomical Therapeutic Chemical classification 0‑L A06AD21 Natriumtartrat WHO Anatomical Therapeutic Chemical classification 0‑L A06AD61 Lactulose, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A06AD65 Macrogol, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A06AG Klysmen WHO Anatomical Therapeutic Chemical classification 0‑L A06AG01 Natriumphosphat WHO Anatomical Therapeutic Chemical classification 0‑L A06AG02 Bisacodyl WHO Anatomical Therapeutic Chemical classification 0‑L A06AG03 Dantron, inkl. Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A06AG04 Glycerol WHO Anatomical Therapeutic Chemical classification 0‑L A06AG06 Öl WHO Anatomical Therapeutic Chemical classification 0‑L A06AG07 Sorbitol WHO Anatomical Therapeutic Chemical classification 0‑L A06AG10 Docusat-Natrium, inkl. Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A06AG11 Laurylsulfat, inkl. Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A06AG20 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A06AH01 Methylnaltrexon bromid WHO Anatomical Therapeutic Chemical classification 0‑L A06AX Andere Laxanzien WHO Anatomical Therapeutic Chemical classification 0‑L A06AX01 Glycerol WHO Anatomical Therapeutic Chemical classification 0‑L A06AX02 Kohlendioxid-freisetzende Mittel WHO Anatomical Therapeutic Chemical classification 0‑L A07 Antidiarrhoika und intestinale Antiphlogistika/Antiinfektiva WHO Anatomical Therapeutic Chemical classification 0‑L A07A Intestinale Antiinfektiva WHO Anatomical Therapeutic Chemical classification 0‑L A07AA Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L A07AA01 Neomycin WHO Anatomical Therapeutic Chemical classification 0‑L A07AA02 Nystatin WHO Anatomical Therapeutic Chemical classification 0‑L A07AA03 Natamycin WHO Anatomical Therapeutic Chemical classification 0‑L A07AA04 Streptomycin WHO Anatomical Therapeutic Chemical classification 0‑L A07AA05 Polymyxin B WHO Anatomical Therapeutic Chemical classification 0‑L A07AA06 Paromomycin WHO Anatomical Therapeutic Chemical classification 0‑L A07AA07 Amphotericin B WHO Anatomical Therapeutic Chemical classification 0‑L A07AA08 Kanamycin WHO Anatomical Therapeutic Chemical classification 0‑L A07AA09 Vancomycin WHO Anatomical Therapeutic Chemical classification 0‑L A07AA10 Colistin WHO Anatomical Therapeutic Chemical classification 0‑L A07AA11 Rifaximin WHO Anatomical Therapeutic Chemical classification 0‑L A07AA12 Fidaxomicin WHO Anatomical Therapeutic Chemical classification 0‑L A07AA51 Neomycin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A07AA54 Streptomycin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A07AB Sulfonamide WHO Anatomical Therapeutic Chemical classification 0‑L A07AB02 Phthalylsulfathiazol WHO Anatomical Therapeutic Chemical classification 0‑L A07AB03 Sulfaguanidin WHO Anatomical Therapeutic Chemical classification 0‑L A07AB04 Succinylsulfathiazol WHO Anatomical Therapeutic Chemical classification 0‑L A07AC Imidazol-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L A07AC01 Miconazol WHO Anatomical Therapeutic Chemical classification 0‑L A07AX Andere intestinale Antiinfektiva WHO Anatomical Therapeutic Chemical classification 0‑L A07AX01 Broxychinolin WHO Anatomical Therapeutic Chemical classification 0‑L A07AX02 Acetarsol WHO Anatomical Therapeutic Chemical classification 0‑L A07AX03 Nifuroxazid WHO Anatomical Therapeutic Chemical classification 0‑L A07AX04 Nifurzid WHO Anatomical Therapeutic Chemical classification 0‑L A07B Intestinale Adsorbenzien WHO Anatomical Therapeutic Chemical classification 0‑L A07BA Kohle-haltige Zubereitungen WHO Anatomical Therapeutic Chemical classification 0‑L A07BA01 Medizinische Kohle WHO Anatomical Therapeutic Chemical classification 0‑L A07BA51 Medizinische Kohle, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A07BB Bismut-haltige Zubereitungen WHO Anatomical Therapeutic Chemical classification 0‑L A07BC Andere intestinale Adsorbenzien WHO Anatomical Therapeutic Chemical classification 0‑L A07BC01 Pektin WHO Anatomical Therapeutic Chemical classification 0‑L A07BC02 Kaolin WHO Anatomical Therapeutic Chemical classification 0‑L A07BC03 Crospovidon WHO Anatomical Therapeutic Chemical classification 0‑L A07BC04 Attapulgit WHO Anatomical Therapeutic Chemical classification 0‑L A07BC05 Diosmectit WHO Anatomical Therapeutic Chemical classification 0‑L A07BC30 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A07BC54 Attapulgit, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A07C Elektrolyte mit Kohlenhydraten WHO Anatomical Therapeutic Chemical classification 0‑L A07CA Elektrolyte zur oralen Rehydrierung WHO Anatomical Therapeutic Chemical classification 0‑L A07D Motilitätshemmer WHO Anatomical Therapeutic Chemical classification 0‑L A07DA Motilitätshemmer WHO Anatomical Therapeutic Chemical classification 0‑L A07DA01 Diphenoxylat WHO Anatomical Therapeutic Chemical classification 0‑L A07DA02 Opium WHO Anatomical Therapeutic Chemical classification 0‑L A07DA03 Loperamid WHO Anatomical Therapeutic Chemical classification 0‑L A07DA04 Difenoxin WHO Anatomical Therapeutic Chemical classification 0‑L A07DA05 Loperamidoxid WHO Anatomical Therapeutic Chemical classification 0‑L A07DA52 Morphin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A07DA53 Loperamid, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A07E Intestinale Antiphlogistika WHO Anatomical Therapeutic Chemical classification 0‑L A07EA Corticosteroide mit lokaler Wirkung WHO Anatomical Therapeutic Chemical classification 0‑L A07EA01 Prednisolon WHO Anatomical Therapeutic Chemical classification 0‑L A07EA02 Hydrocortison WHO Anatomical Therapeutic Chemical classification 0‑L A07EA03 Prednison WHO Anatomical Therapeutic Chemical classification 0‑L A07EA04 Betamethason WHO Anatomical Therapeutic Chemical classification 0‑L A07EA05 Tixocortol WHO Anatomical Therapeutic Chemical classification 0‑L A07EA06 Budesonid WHO Anatomical Therapeutic Chemical classification 0‑L A07EA07 Beclometason WHO Anatomical Therapeutic Chemical classification 0‑L A07EB Antiallergika, exkl. Corticosteroide WHO Anatomical Therapeutic Chemical classification 0‑L A07EB01 Cromoglicinsäure WHO Anatomical Therapeutic Chemical classification 0‑L A07EC Aminosalicylsäure und ähnliche Mittel WHO Anatomical Therapeutic Chemical classification 0‑L A07EC01 Sulfasalazin WHO Anatomical Therapeutic Chemical classification 0‑L A07EC02 Mesalazin WHO Anatomical Therapeutic Chemical classification 0‑L A07EC03 Olsalazin WHO Anatomical Therapeutic Chemical classification 0‑L A07EC04 Balsalazid WHO Anatomical Therapeutic Chemical classification 0‑L A07F Mikrobielle Antidiarrhoika WHO Anatomical Therapeutic Chemical classification 0‑L A07FA Mikrobielle Antidiarrhoika WHO Anatomical Therapeutic Chemical classification 0‑L A07FA01 Milchsäurebildner WHO Anatomical Therapeutic Chemical classification 0‑L A07FA02 Saccharomyces boulardii WHO Anatomical Therapeutic Chemical classification 0‑L A07FA51 Milchsäurebildner, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A07X Andere Antidiarrhoika WHO Anatomical Therapeutic Chemical classification 0‑L A07XA Andere Antidiarrhoika WHO Anatomical Therapeutic Chemical classification 0‑L A07XA01 Albumintannat WHO Anatomical Therapeutic Chemical classification 0‑L A07XA02 Ceratonia WHO Anatomical Therapeutic Chemical classification 0‑L A07XA03 Calcium-haltige Verbindungen WHO Anatomical Therapeutic Chemical classification 0‑L A07XA04 Racecadotril WHO Anatomical Therapeutic Chemical classification 0‑L A07XA51 Albumintannat, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A08 Abmagerungsmittel, Exkl. Diätetika WHO Anatomical Therapeutic Chemical classification 0‑L A08A Abmagerungsmittel, Exkl. Diätetika WHO Anatomical Therapeutic Chemical classification 0‑L A08AA Zentral wirkende Abmagerungsmittel WHO Anatomical Therapeutic Chemical classification 0‑L A08AA01 Phentermin WHO Anatomical Therapeutic Chemical classification 0‑L A08AA02 Fenfluramin WHO Anatomical Therapeutic Chemical classification 0‑L A08AA03 Amfepramon WHO Anatomical Therapeutic Chemical classification 0‑L A08AA04 Dexfenfluramin WHO Anatomical Therapeutic Chemical classification 0‑L A08AA05 Mazindol WHO Anatomical Therapeutic Chemical classification 0‑L A08AA06 Etilamfetamin WHO Anatomical Therapeutic Chemical classification 0‑L A08AA07 Cathin WHO Anatomical Therapeutic Chemical classification 0‑L A08AA08 Clobenzorex WHO Anatomical Therapeutic Chemical classification 0‑L A08AA09 Mefenorex WHO Anatomical Therapeutic Chemical classification 0‑L A08AA10 Sibutramin WHO Anatomical Therapeutic Chemical classification 0‑L A08AA56 Ephedrin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A08AB Peripher wirkende Abmagerungsmittel WHO Anatomical Therapeutic Chemical classification 0‑L A08AB01 Orlistat WHO Anatomical Therapeutic Chemical classification 0‑L A09 Digestiva, Inkl. Enzyme WHO Anatomical Therapeutic Chemical classification 0‑L A09A Digestiva, Inkl. Enzyme WHO Anatomical Therapeutic Chemical classification 0‑L A09AA Enzym-haltige Zubereitungen WHO Anatomical Therapeutic Chemical classification 0‑L A09AA01 Diastase WHO Anatomical Therapeutic Chemical classification 0‑L A09AA02 Multienzyme (Lipase, Protease etc.) WHO Anatomical Therapeutic Chemical classification 0‑L A09AA03 Pepsin WHO Anatomical Therapeutic Chemical classification 0‑L A09AA04 Tilactase WHO Anatomical Therapeutic Chemical classification 0‑L A09AB Säure-haltige Zubereitungen WHO Anatomical Therapeutic Chemical classification 0‑L A09AB01 Glutaminsäurehydrochlorid WHO Anatomical Therapeutic Chemical classification 0‑L A09AB02 Betainhydrochlorid WHO Anatomical Therapeutic Chemical classification 0‑L A09AB03 Salzsäure WHO Anatomical Therapeutic Chemical classification 0‑L A09AB04 Zitronensäure WHO Anatomical Therapeutic Chemical classification 0‑L A09AC Enzym- und Säure-haltige Zubereitungen, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A09AC01 Pepsin- und Säure-haltige Zubereitungen WHO Anatomical Therapeutic Chemical classification 0‑L A09AC02 Multienzyme und säure-haltige Zubereitungen WHO Anatomical Therapeutic Chemical classification 0‑L A10 Antidiabetika WHO Anatomical Therapeutic Chemical classification 0‑L A10A Insuline Und Analoga WHO Anatomical Therapeutic Chemical classification 0‑L A10AA Insulins WHO Anatomical Therapeutic Chemical classification 0‑L A10AB Insuline und Analoga zur Injektion, schnell wirkend WHO Anatomical Therapeutic Chemical classification 0‑L A10AB01 Insulin (human) WHO Anatomical Therapeutic Chemical classification 0‑L A10AB02 Insulin (Rind) WHO Anatomical Therapeutic Chemical classification 0‑L A10AB03 Insulin (Schwein) WHO Anatomical Therapeutic Chemical classification 0‑L A10AB04 Insulin lispro WHO Anatomical Therapeutic Chemical classification 0‑L A10AB05 Insulin aspart WHO Anatomical Therapeutic Chemical classification 0‑L A10AB06 Insulin glulisin WHO Anatomical Therapeutic Chemical classification 0‑L A10AB30 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A10AC Insuline und Analoga zur Injektion, intermediär wirkend WHO Anatomical Therapeutic Chemical classification 0‑L A10AC01 Insulin (human) WHO Anatomical Therapeutic Chemical classification 0‑L A10AC02 Insulin (Rind) WHO Anatomical Therapeutic Chemical classification 0‑L A10AC03 Insulin (Schwein) WHO Anatomical Therapeutic Chemical classification 0‑L A10AC04 Insulin lispro WHO Anatomical Therapeutic Chemical classification 0‑L A10AC30 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A10AD Insuline und Analoga zur Injektion, intermediär wirkend kombiniert mit schnell wirkend WHO Anatomical Therapeutic Chemical classification 0‑L A10AD01 Insulin (human) WHO Anatomical Therapeutic Chemical classification 0‑L A10AD02 Insulin (Rind) WHO Anatomical Therapeutic Chemical classification 0‑L A10AD03 Insulin (Schwein) WHO Anatomical Therapeutic Chemical classification 0‑L A10AD04 Insulin lispro WHO Anatomical Therapeutic Chemical classification 0‑L A10AD05 Insulin aspart WHO Anatomical Therapeutic Chemical classification 0‑L A10AD30 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A10AE Insuline und Analoga zur Injektion, lang wirkend WHO Anatomical Therapeutic Chemical classification 0‑L A10AE01 Insulin (human) WHO Anatomical Therapeutic Chemical classification 0‑L A10AE02 Insulin (Rind) WHO Anatomical Therapeutic Chemical classification 0‑L A10AE03 Insulin (Schwein) WHO Anatomical Therapeutic Chemical classification 0‑L A10AE04 Insulin glargin WHO Anatomical Therapeutic Chemical classification 0‑L A10AE05 Insulin detemir WHO Anatomical Therapeutic Chemical classification 0‑L A10AE30 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A10AF Insuline und Analoga zur Inhalation WHO Anatomical Therapeutic Chemical classification 0‑L A10AF01 Insulin (human) WHO Anatomical Therapeutic Chemical classification 0‑L A10B Antidiabetika, Exkl. Insuline WHO Anatomical Therapeutic Chemical classification 0‑L A10BA Biguanide WHO Anatomical Therapeutic Chemical classification 0‑L A10BA01 Phenformin WHO Anatomical Therapeutic Chemical classification 0‑L A10BA02 Metformin WHO Anatomical Therapeutic Chemical classification 0‑L A10BA03 Buformin WHO Anatomical Therapeutic Chemical classification 0‑L A10BB Sulfonylharnstoff-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L A10BB01 Glibenclamid WHO Anatomical Therapeutic Chemical classification 0‑L A10BB02 Chlorpropamid WHO Anatomical Therapeutic Chemical classification 0‑L A10BB03 Tolbutamid WHO Anatomical Therapeutic Chemical classification 0‑L A10BB04 Glibornurid WHO Anatomical Therapeutic Chemical classification Dieses Value Set beinhaltet 6063 Codes. Um die Publikationsgröße überschaubar zu halten, wird nur eine Auswahl (500 Codes) des ganzen Sets von Codes gezeigt.
Legende: Typ L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavor OTH (other) schlägt Text in originalText vor. HL7 V3: NullFlavors werden im @nullFlavor Attribut statt in @code angegeben.

1.2 Zusammenstellung aller Versionen dieses Value Sets

• 2013-01-10 (Definitiv)